MEXICO CITY — Pérez Correa González (PCG) has announced the appointment of Mariana Larrea as partner in its Life Sciences & Pharma practice, reinforcing the firm’s capabilities in one of the country’s fastest-evolving and most highly regulated sectors.
Larrea joins the partnership with more than 12 years of experience advising domestic and multinational companies on complex regulatory and corporate matters involving pharmaceuticals, medical devices, food and beverages, consumer products, and healthcare. Her arrival reflects the firm’s continued investment in industries where regulatory compliance, innovation, and market expansion increasingly intersect.
Over the course of her career, Larrea has practiced at several of Mexico City’s leading law firms, developing a reputation for guiding clients through the country’s regulatory framework governing health products, consumer protection, advertising, and market access. Her work spans the regulation of pharmaceuticals, medical devices, food and beverage products, alcoholic beverages, health-risk substances, and the commercialization and promotion of regulated goods.
She also advises clients on corporate transactions, commercial contracts, and strategic regulatory planning, helping companies navigate evolving legal requirements while supporting business growth and operational objectives.
She is frequently invited to participate in conferences, industry forums, and expert panels across the United States and Europe, where she discusses developments in healthcare regulation, consumer protection, food and beverage law, and the emerging cannabis industry.
Her thought leadership has focused on the legal and policy challenges created by rapidly changing regulatory environments, providing practical insight to companies operating in highly regulated markets.
With Larrea’s appointment, Pérez Correa González further expands its multidisciplinary Life Sciences & Pharma practice, offering clients integrated legal advice across regulatory, corporate, transactional, compliance, and commercial matters. T
The firm continues to advise national and international companies facing increasingly sophisticated legal and regulatory challenges in Mexico’s healthcare and consumer products industries.
The appointment underscores the growing demand for specialized legal counsel in life sciences and pharmaceutical regulation as companies navigate heightened regulatory scrutiny, evolving public health policies, and continued innovation across the sector.
